再鼎医药(09688.HK)授出1.2万份购股权及2.3万股受限制股份单位

Core Viewpoint - Zai Ding Pharma (09688.HK) announced the grant of stock options and restricted stock units under its 2024 equity incentive plan, indicating a strategic move to incentivize key personnel and align their interests with the company's performance [1] Group 1 - The company granted a total of 11,800 American Depositary Shares (ADS) stock options to 3 grantees [1] - Additionally, the company awarded a total of 22,665 restricted stock units (RSUs) to 6 grantees [1] - The grants are set to take effect on December 1, 2025, Eastern Time [1]